|
| 38096371 | Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML. | Blood | 2024 |
| 36669140 | Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group. | J Clin Oncol | 2023 |
| 37715723 | Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcoma. | | 2023 |
| 37956387 | Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research. | JCO Clin Cancer Inform | 2023 |
| 36780200 | Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA. | | 2023 |
| 36592003 | Tumor biology, biomarkers, and liquid biopsy in pediatric renal tumors. | Pediatr Blood Cancer | 2023 |
| 36996377 | Clinical Targeted Next-Generation Panel Sequencing Reveals <i>MYC</i> Amplification Is a Poor Prognostic Factor in Osteosarcoma. | JCO Precis Oncol | 2023 |
| 37306107 | Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma. | Cancer Med | 2023 |
| 36993649 | The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study. | Res Sq | 2023 |
| 36724417 | Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. | J Clin Oncol | 2023 |
| 35325095 | Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression. | Clinical Cancer Research | 2022 |
| 35512711 | Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. | Am J Hum Genet | 2022 |
| 35580298 | Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. | Journal of Clinical Oncology | 2022 |
| 36221002 | Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group. | Br J Cancer | 2022 |
| 35561344 | Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma. | Clinical Cancer Research | 2022 |
| 35809374 | Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group. | Eur J Cancer | 2022 |
| 35739269 | Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. | Nat Med | 2022 |
| 35984457 | Serrated Polyposis Syndrome in a Young Adolescent Patient. | J Pediatr Gastroenterol Nutr | 2022 |
| 36115869 | An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. | NPJ Precis Oncol | 2022 |
| 35347250 | Rapid and highly sensitive approach for multiplexed somatic fusion detection. | Modern Pathology | 2022 |
| 34964003 | Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor. | JCO Precis Oncol | 2021 |
| 34129824 | STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma. | Cancer Cell | 2021 |
| 33769463 | Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma. | Arch Pathol Lab Med | 2021 |
| 32667141 | Making the most of small samples: Optimization of tissue allocation of pediatric solid tumors for clinical and research use. | Pediatric Blood and Cancer | 2020 |
| 32483734 | Using Liquid Biopsy in the Treatment of Patient with OS. | Advances in Experimental Medicine and Biology | 2020 |
| 32598183 | Chasing ctDNA in Patients With Sarcoma. | American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting | 2020 |
| 30880335 | Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. | Br J Cancer | 2019 |
| 30614191 | Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies. | Pediatric Blood and Cancer | 2019 |
| 30979745 | High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma. | Clin Cancer Res | 2019 |
| 30860482 | Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibition. | Elife | 2019 |
| 30793095 | Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease. | JCO Precision Oncology | 2019 |
| 31392992 | EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex. | Nucleic Acids Res | 2019 |
| 31355930 | Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group. | Cancer | 2019 |
| 31240271 | Duality of purpose: Participant and parent understanding of the purpose of genomic tumor profiling research among children and young adults with solid tumors. | JCO Precis Oncol | 2019 |
| 30131550 | Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. | Br J Cancer | 2018 |
| 30027144 | Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. | JCO Precis Oncol | 2018 |
| 29997151 | Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response. | Mol Cancer Ther | 2018 |
| 29206863 | Blood collection in cell-stabilizing tubes does not impact germline DNA quality for pediatric patients. | PLoS One | 2017 |
| 26822149 | Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study. | JAMA Oncol | 2016 |
| 27429135 | Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience. | Pediatr Blood Cancer | 2016 |
| 27329820 | Integrated genetic and pharmacologic interrogation of rare cancers. | Nat Commun | 2016 |
| 27132463 | Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop. | Cancer Genet | 2016 |
| 26337082 | Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. | Oncotarget | 2015 |
| 26006721 | CSF 5-Methyltetrahydrofolate Serial Monitoring to Guide Treatment of Congenital Folate Malabsorption Due to Proton-Coupled Folate Transporter (PCFT) Deficiency. | JIMD Reports | 2015 |
| 25186949 | The genomic landscape of pediatric Ewing sarcoma. | Cancer Discov | 2014 |
| 25401475 | Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. | J Clin Invest | 2014 |
| 23536552 | High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma. | Cancer Res | 2013 |
| 23770567 | Mutational heterogeneity in cancer and the search for new cancer-associated genes. | Nature | 2013 |
| 19740703 | Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter. | Clinical Immunology | 2009 |
| 16123980 | Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. | Pediatric Blood and Cancer | 2006 |